Emami Limited (EMAMILTD) Q1 2027 Earnings Call Transcript

Ladies and gentlemen, good day, and welcome to Imami Q1 FY27 Earnings Conference Call. As a reminder, all participant lines will be in listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing star, then zero, or near touchstone phone. Please note that this conference is being recorded. I now hand the conference over to Mr. Percy Pantaki from IIFL. Thank you, and over to you, sir.

Hi, good evening, everyone. I have the pleasure to host the management of Imami Ltd. for their quarterly conference call. On the line with me, I have Mr. Mohan Goenka, whole-time director and vice chairman, Mr. Vivek Deer, CEO, International Business, Mr. Gulraj Bhatia, President, Healthcare, Mr. Manish Gupta, President, Sales, Mr. Dhru Agarwal, Chief Growth Officer, and Mr. Rajesh Sharma, President, Finance and IR. I'll hand over the call to Mr. Mohan Goenka for his initial comments, and then we'll open up for Q&A. Over to you, sir.

Yeah.

Good afternoon, ladies and gentlemen. Thank you for joining us today for Imami Limited's Q1 FY27 Learning Call. I am pleased to report that our consolidated revenue grew by 15% to 1039 crores during the quarter. Our domestic business grew by 20% and on a like-to-like basis. Growth stood at a healthy 12% with a volume growth of 8% after considering the previous year numbers of two of our startups, Axiom and Inknut. As our business continues to evolve, we are also transitioning our disclosure framework from brand-wise reporting to category-wise reporting. This reflects the increasing scale and diversification of our portfolio. and provides a more holistic view of performance across key consumer segments and aligns our reporting framework with industry practices. More details on this is available in our presentation. So coming to our category performance, hair and scalp care emerged as one of our strongest performing categories, delivering 11% growth during the quarter. Within the portfolio, Navratna Cool Oil posted strong double-digit growth. While Case King reported mid-single-digit growth. Seven oils in one once again delivered robust growth, reinforcing its position as one of the fastest-growing brands in our portfolio. Skincare grew by 3% during the quarter. While the summer season was characterized by significant regional divergence, our talc portfolio delivered high single-digit growth. The male grooming range and BoroPlus registered low single-digit growth, respectively. Healthcare grew by 2% during the quarter. The OTC portfolio continued to perform strongly and grew in high teens, while Medico range posted single-digit growth. The standout performance, however, continued to be our strategic investment portfolio. On a like-to-like basis, this portfolio grew by an impressive 61%, which now contributes 18% of our domestic business, highlighting the increasing relevance of our new-age growth engine. The man company and Brilair continue to deliver strong momentum, supported by premiumization trends and growing digital adoption. We are equally encouraged by the performance of our recently acquired businesses. Both Axiom Ayurveda and Inknut have started their journey within the Imami ecosystem on a strong footing and are delivering encouraging underlying like-to-like growth. Taken together, the quarter performance reinforces our belief that Imami today is no longer dependent on a few core categories or brands. We are building a much more diversified portfolio spanning traditional FMCG categories, personal and healthcare, premium beauty and grooming, digital first brands and emerging consumer platforms. This diversification not only broadens our growth runway, but also enhances the resilience of our business model across varying economic and consumption cycles. Our channel transformation journey also continues to gather pace. Organized channels grew by 19% on a like-to-like basis and today contributes to 32% of our domestic business. Modern trade and e-com maintain strong momentum with quick-com now contributes 35% of our e-com business. International business declined by 12% during the quarter, primarily due to disruptions in the West-Asia conflict, which constraint our ability to execute orders. Despite the near-term headwinds, the underlying strength of our international franchise remains intact. We have used this period to strengthen market fundamentals, improve pricing architecture, and enhance operational agility. And remain confident of progressively regaining momentum and delivering healthy growth in the coming quarters. On profitability, the quarter witnessed inflationary pressures led by higher crude oil prices and sustained cost increases across packaging material, making it one of the challenging cost environments for the sector in recent years. These factors together with the changing business mix following the integration of the acquired businesses Resulting in higher COGS and moderation in gross margin compared to last year. While we undertook measured price increases to mitigate the impact of cost inflation, the SAR price in input costs during the quarter weighed on profitability. Given the current commodity cost trajectory, we are implementing further pricing actions and expect To more than offset the absolute increase in input costs during the financial year. We continue to focus on productivity enhancements, procurement efficiencies, and value-led revenue management initiatives to strengthen margins and deliver sustained, profitable growth. However, I am pleased to highlight that despite of these cost pressures, EBITDA grew by 6% to 226 crores and profit before tax grew by 4%. This reflects the resilience of our business model and the effectiveness of the numerous cost management initiatives undertaken during the quarter. Profit after tax stood at 137 crores, lower by 16% due to normalization of our effective tax rate. As part of our ongoing transformation journey, We are executing three strategic initiatives to strengthen our growth platform and improve business efficiency. We are enhancing supply chain planning, inventory management, and distribution visibility, which will help improve forecast accuracy, service levels, and working capital efficiency. Sales code AI is being deployed to make our sales organization more productive by enabling better planning, sharper execution, and real-time decision support for the field force. At the same time, our analytical hub is creating a single enterprise-wide platform for data, analytics, and AI, enabling faster access to insights and better decision-making across the organizations. These initiatives are progressing very well and are expected to be completed during the current financial year. As we look ahead, we remain very optimistic about the growth prospects for the business. We are encouraged by the strong performance of our code brands, rapid scaling of our digital first brands, and sustained traction in modern trade, e-com and quick-com channels. With commodity inflation and geopolitical developments remains areas to watch. We believe our diversified portfolio, strengthened distribution capabilities, robust innovation pipeline, and disciplined cost management initiatives positions as well to deliver sustained and profitable growth through the remainder of FY27. With that, I would now like to open the floor for questions. Thank you.

Thank you very much. We will now begin with the question and answer session. Anyone who wishes to ask a question may press star and 1 on their touchtone telephone. If you wish to remove yourself from the question queue, you may press star and 2. Participants are requested to use handsets while asking a question. Ladies and gentlemen, we will wait for a moment while the question queue assembles. The first question comes from the line of Abhinesh Roy from Nuwama. Please go ahead.

Yeah, thank you. My first question is on strategic investment. So, 61% growth is strong. If you could tell us in the fourth sub-segment which one is driving this growth. Some of these are quite new. For example, Axiom became a subsidiary in Q1 only and Incut again from Q1 only. So, some of these are quite new. I understand 61% like-to-like is comparing from the base, but still, if you can explain this strong growth, how sustainable is it, where is it coming from, and company, of course, last two, three years has been reasonably challenging, so is it a base effect?

Yeah.

So, Abhinish, Dhruv is driving this business, and I would request Dhruv to take this.

Sure. So, I think across all four of the subsidiaries that are represented over here, we've grown substantially, both in terms of volume and value. When it comes to Axiom, while it is a new subsidiary, it's a new majority stake that we have, we've been involved since 2023. So we've got, you know, very, you know, since last year, we've been working on some of the initiatives that have started to reap the rewards. So overall, yes, it's been, you know, it's been very good, 60%. But, you know, even PNC, which was struggling, like you said, over the last two years, that's grown north of 20%. You know, well, well north of 20%. So, you know, it's actually across all. The only one I think that is slightly newer is Inknut in the portfolio. But, you know, we're getting our hands dirty with that brand very, very quickly.

But how sustainable is this? 61%, is there anything one-off, any pipeline build-up due to new launches? For the balanced three-quarters, what is the expectation on growth?

I think you will see something similar. So, this is quite sustainable.

Understood.

Last question on this new framework for reporting, category-led reporting. I wanted to understand the thought process of doing this now because in one or two segments, frankly, it looks good to do category reporting. But what do I do with skin care, for example, which has got talcum powder, which is very seasonal. You have clubbed that with Smart and Handsome and Goro Plus, which is a very different segment. So how does this help in terms of data point, if you could tell? I think same issue will be also in health care. Pain management, again, is quite seasonal. And then you have clubbed that with Jandu Healthcare, which is far more... I think strategic in nature, far more evenly balanced out every quarter. So if you could tell us how does this help? I understand category reporting a lot of other companies are doing, but how does this help?

Now, Avni, someday we had to start this because with so many brands coming in, you know, it was not possible for us to give brand-wise information. Okay. Clubbings can be different for each company, but Baam being a Jandu brand and Baam being a healthcare, you know, the brand name is also Jandu. So we wanted to club it with the healthcare only. It is primarily a healthcare and it is not so seasonal. So, you know, sometimes people really get confused with seasonal, non-seasonal, you know, and with now almost 10-12 brands, you know, we have to club. We can't give each brand reporting. Understood. So, that's all from me.

Thank you.

Thank you.

And there are more brands in the pipeline we are looking for. So, how do we keep on reporting brand-based information?

Understood. Thank you. The next question comes from the line of Arnab Mitra from Goldman Sachs. Please go ahead.

Yeah, hi, Mohanji. My first question is on margins. So the impact that you have seen this quarter, how much of it is to do with the input cost and how much of it you would say is structural because your portfolio is changing towards these new categories? And the impact which is from commodities given your pricing power, do you expect to offset it completely over a period of a couple of quarters? Or do you think the pressure is so much that there is going to be an impact for the remaining nine, three quarters also of the year?

Yeah, so Arnab, our input cost, if you would see, has gone up by 360 basis points, okay, and out of which almost 200 basis points is due to the conflict, West Asia conflict, and the balance 160 is because of the mix. So, now that the pressure is also easing a bit, we are very confident on that front that we will be able to offset with increased prices. As far as the mix is concerned, see, that would be difficult because the startups have lower margins. But we are trying our best to also see that how can we, you know, increase some pricing to offset that increase also. I'm not worried for the whole year, Arnav, very honestly. I think the next three quarters should be relatively better than this.

Got it. Mohanji, my second question is on talcum powder, where I think last year, full year, FY26, there was a large decline over the base year. Now, in this category, now that let's say this year is a normal year with a good summer, should we not expect the revenue to go back to the FY25 level in talcum powder? Or do you think fundamentally the revenue there is not going to, the growth or the recovery is not going to be a full recovery in terms of at least getting back to the older levels of revenue? Because that is what seems to have driven the slowdown in the skincare business this time.

Absolutely, we are absolutely right. So, we would be able to recover, you know, and go back to the 25 numbers. Last year was a low number, but this year we are going to make up. You will see a substantially high numbers in this quarter for TALC.

Got it, got it.

For the whole year, you will see a significantly high numbers.

Got it, got it. And my last question was on international business where there has still been a decline. Now, in most other companies, what we have seen is most companies have now figured out a way to operate, you know, those companies who had a Middle East base. So, have you also been able to figure out other logistics so that you can, your international business can recover? Or do you think till the hormones is closed, there is going to be a decline in the foreseeable future?

Vivek, who do you want to answer?

Yeah. So our portfolio is slightly different from the rest of the companies, which are essentially into only personal care. We are into OTC space pain management as well in Middle East. So the pain management is all produced out of India only. So personal care is produced in UAE as well as Germany, and a part of that is being produced in Thailand. Over there, we are not having much of the issue. So that is being fully resurrected. But the OPC, pain management space, we are still struggling because certain pain management space, other things, have still not been able to move out of India. And we are having hefty orders with us, not able to move. We are trying to find solutions to get some approvals from the ministries. And hopefully in a few days we should be able to get something moved from India. In that regard, when that is sorted, then we should be fully sorted. In terms of supply reinstatement to the markets. So that is where we are struggling today. But the rest of the, I think, personal care side, we are clearly, I think, balanced now.

Got it, understood. That's it from my side.

And on the international front, I think the decline, this is now done, most likely you will see a significant growth coming in from the third and the fourth quarter. Because we have realigned our, a lot of international business strategies have been realigned in the last one, two quarters when all these deceptions were happening. So I think, you know, you will see much better numbers in third and fourth quarters.

Thank you. The next question comes from the line of Harit Kapoor from Investec. Please go ahead.

Hi, good evening. The first question is on strategic investments portfolio. So, just wanted to get a sense of, you know, whether there is any seasonality in this part of the portfolio, you know, across the four brands that we have. Just wanted to understand whether this 160 odd crores can be broadly annualized to look at a yearly number. So, that's my first question.

So, I think Axion has some level of seasonality because it's juices and summer is a better season for us. But, you know, in terms of analyzing the figure, I think, you know, because the internet, I think only one month's value will be reported in these numbers. You know, generally, if you analyze it, you should be, you know, fairly accurate in terms of what we're aiming for.

There's not much seasonality, Harith, other than just the Axiom juice business, which out of the total portfolio should not be more than 7-8%, if you see pure seasonality.

If I'm not wrong, Dhruv? No, absolutely. I think the next two quarters actually are high season for TMC and Breler because, you know, that's festive. And that's where we do a lot of our sales, even these are G2C brands. So, we've got a task ahead of us over the next two quarters.

Yeah.

And the second bit was, you know, given that, you know, there's been consolidation as well as acquisition in the last few months, do we expect that, you know, so will 27 be a year of, you know, where we kind of consolidate these four acquisitions, see them grow or build them out and then maybe look for incremental opportunities? Is that something ongoing and one can even see more such initiatives even in the near to medium term?

I think we are doing this in parallel. We think we've built a repeatable model at the center where we are able to help each of these companies grow, right? And I think across all of our brands, there is not one that hasn't grown, right? So we're quite happy with the repeatable model. Of course, new capabilities constantly need to be added. And so if we can get two or three more engines inside the two or three more acquisitions, then why not? So we are looking very aggressively in parallel to see who else, you know, we can roll up there.

Got it. And last bit, again, is on the strategic investments. You did mention the gross margin impact because of mix, but just wanted to get a range of, you know, these four brands now at an aggregate level. You know, what are the kind of EBITDA margin levels for this business at Novara level? Are you at break-even levels? Are you below break-even? You know, is it low single, mid-single? Just some color on, because I think some of them are at the lower end, some of them are actually quite profitable. So at an aggregate level, how does that look like?

Yeah, it's a mix because, you know, each of these brands are at different stages of growth. And of course, I'd like to think that all of them are ready for, you know, strong growth. At an aggregate level, I think they're about a beta-neutral break-even.

Those are my questions. I will come back to the phone. Thank you. Thank you.

Thank you. The next question comes from the line of Loibhav Gupta from Bowhead Investment. Please go ahead.

Hi, sir. Thanks for taking my question. Wanted to understand what is the high other income figure in a standalone number. So it is 53 crores.

Hi, Vaibhav. It includes a dividend from one of our international subsidiaries amounting to roughly 32 crores, which gets knocked off in consolidation. Understood. Understood.

And my next question is, so, sir, we had revamped our case king portfolio and it was seeing good growth in H2 of last year, but the growth has slowed down in this quarter. So, could you share what has been happening?

Growth has been mid-high single-digit growth by above. So it will be like, you know, some quarters because maybe of some base effect and all, but we are expecting a double-digit growth at the end of the year for Keshki portfolio. There's nothing to worry.

Understood. And how was the growth in Braille? Really interesting. Brands wanted to see if you could call out the growth rates in there.

I think individual growth rates, we're not falling out, but Belair had a fabulous year. I think the rosemary oil shorts are really paying dividends for us, and consumers are really happy with that product. You know, so that's where I think we had, you know, well above the average growth.

Understood. Thank you so much.

For the whole year, for all these startups, like for this quarter, we did 160 crores. By the end of the year, I think we will be ending up anywhere between 750 to 800 crores.

That's great, sir. Thank you.

Thank you. The next question comes from the line of Percy Pentaki from IIFL. Please go ahead.

Yeah, I'm audible.

Yes.

Yeah. So just wanted to understand on the D2C businesses, how are you running them right now? Are they running as four separate companies altogether and that will continue in future? Or you are planning to sort of have some kind of synergies or some kind of bundling of some of the functions? So, and also, how will the organization structure of this sort of strategic investments division look like, let's say, a year from now?

Yeah. So, right now, they are being run independently with their own CEO. I think we have a growth office that's about, you know, seven, eight members. That is the link between Inhami and these startups, and the family is very closely involved in making sure that these startups are growing. We provide all the support that we need, whether it is content or international business or strategy or relationships with e-commerce or, you know, GT, SAMT channel. So I think that that goes through me and my office. And so wherever we are able to help independently, you know, we do that. Plus, within these companies, there's a lot of knowledge sharing and experience sharing, so, you know, that has also really helped in accelerating the pace of growth, right? I think a year from now, also, we expect to maintain a similar sort of structure. We might bolster the central team and see what capabilities we can offer because now it's more of a plug-and-play into, you know, our repeatable model, as I mentioned earlier. So, but, but I think we like the. For the near term, at least next one year, we will keep it in this way.

And what is the margin for the business?

Parsi, so by and large, as far as we are concerned, Dhruv has almost a free hand to run the business. He runs this business out of Gurgaon, and the entire team is based out of Gurgaon. So, because this needs a different, you know, strategy and, you know, people. So, you know, we have very aggressive plans, as we said, going forward for strategic investments. And we are looking for more such acquisitions. So I think the team is by and large built under this thing. And as he said, all of these companies have very senior, you know, talent, who are the CEOs for each individual businesses. So, and the business, once we end this year by 700-800 crores, you know, growing at almost 20-30% year on year. So, you know, it needs a different strategy and pace. And management is completely committed to invest behind these fast-growing segments.

Understood.

Also, when we need people, you know, he is free to appoint them.

Yeah, sure. Guru, can you help us understand what is, I mean, not asking separately for the four different companies, but for strategic investments as a whole, what is the kind of margin structure that you have? What is the, like, at a gross margin as well as a EBITDA margin level?

From a gross margin perspective, you know, companies like TNC are north of 60%. Companies like Breler and Ignat are north of 70%. From an EBITDA perspective, I think I'll only be able to comment on the aggregate where, you know, we are close to or at EBITDA neutral. But, you know, going forward, I will take some calls regarding, you know, where I see a good opportunity to grow and where I see a good opportunity to make profit. I think there is a long-term target, you know, two-three-year target where we will get to a healthy amount of profitability. But if there is momentum right now, then we don't want to give up on that. Because, you know, any growth in our top line at startups that are between 100 to 300 crores will only offset our pickpots and help us in the long term.

Sure, sure.

So, how long do you think... Nowhere, sorry, I'm coming in here. See, none of our four startups have gross margin below 55. Axiom may be slightly lower, but others are much above, yeah, more than 50%. Yeah. Am I correct?

Yes, absolutely. I mean, when it comes to BPC, we are looking at, I mean, the criteria for investing itself is high work margin, and we're looking at, you know, low performance marketing spend, more brand marketing spend, we've reoriented our entire brand investments towards, you know, content, media, less offers, and so on. So, I think it's all building for the long term.

So, how long do you think it would take for the overall vertical strategic investments overall to sort of go to, let's say, a low-teens kind of EBITDA margin? Would it be like a two-to-three-year perspective, or would it be more like a five-year kind of horizon?

So, you know, this is growing so quickly that it's hard for me to pinpoint. But I think, you know, you would expect high single-digit probably at the three-year point, and then we'll take it from there.

Understood. And lastly, could you give me the channel split in terms of I'm assuming that there is no brick and mortar or if at all, let me know about that as well. But within the online portion, what is the split between your own website or app or whatever and versus third party websites or apps?

You see, in aggregate, it would be very... It will be very different because, you know, for a company like Inknut, which does personalized hair care, there I'm largely on my website. For a company like Breler or TNC, I'm going to the channel where my consumers are going. So that's good commerce, e-commerce, while we use our, you know, website for first-party data, and there's a ton of creative things that we can do with that. Axiom actually has a phenomenal offline network. So most of our sales there are offline across states from north to south. We sell in Jammu, we sell in Tamil Nadu, we sell everywhere through an offline network. So there, actually, the job is to build more online presence, more quick commerce presence.

So at an overall level for the entire vertical, roughly, what would be a split between own assets, third-party digital assets and offline?

At an overall level, I think you can put maybe 20% offline, I think 20% own assets, and then the remaining will be, sorry, probably 25 to 30% own assets, and the remaining will be e-com, quick-com, and other platforms.

Okay, got it, got it. Yeah, I think my questions are answered. We don't have anyone in the queue right now, but if anyone wants to ask a question, they can press star 1 and we'll take it, or else we can close the call. Yeah, there is one. Asarva, you can go ahead. Thank you.

The next question comes from the line of Kostav Bhubna from BMSPL Capital. Please go ahead.

Yeah, so please explain to me this, you know, a little bit more about the margin trajectory, given that the new brands, as in the startups, the investments that we're in, is lower margin. So, and that's... As of now, that's where the main growth is coming from. So that's low margin growth. Just explain to me, X of these low margin businesses which are growing, what about the businesses which command margin? What's the outlook over there? Because if we want to...

So, Kostob, as I said, for the year, I don't see that as a big worry. Right now, because of this West Asia, There was some pressure on our gross margins. But I see that bouncing back very quickly. We have also taken aggressive price increases wherever needed. So I don't see a margin pressure going forward. Also, there is a clear target for startups for part two profitability. So there also most of our startups have reduced losses in this quarter compared to last year. So, don't worry about this low-margin businesses growing faster, because that's the consumer ask also. We can't just rely on certain baskets where margins are very high, and the growth is coming from different, so there has to be a good balance. But despite of all this, we are committed that our margins don't come down. That's a task that we have, and I'm confident that we'll be able to maintain our margins.

Now, when you say margins won't come down, do you mean from the last two quarters base of around 20 to 22 percent, if you don't include other income, or do you mean, because, you know, the last two quarters margin has been relatively lower than previous quarters, so… So, what type of operating margin range before the income should we expect?

As I said, Kostav, it is short term because of the West Asia conflict. Once it gets settled, we will have to wait and see. We are confident that we will be able to gain in coming quarters with our aggressive price increases in some of our core businesses.

Okay, great. Thank you so much.

Thank you. The next question comes from the line of Vaibhav Gupta from Boat Management. Please go ahead.

Yes, sir. Sir, I wanted to understand that tax rate seemed a bit high this quarter, like it was 28-29%. So, is this our normal tax rate going forward or it could come down a bit?

It should be around 25-26% this year because till last year we were enjoying some fiscal benefits. And from this year, we are back to normal taxation of 25%. Understood.

And sir, given Keshking would have a very low base last year, so despite that growing at mid-single digit, it seems a bit low. Are we taking any further initiatives or entering any new geographies to address this thing?

The cost of Keshking is back on traction. Whatever initiatives had to be taken, have taken. We have arrested our degrowth and it is now growing. There are a couple of new launches coming under Keshking, mostly in the D2C space. There is a lot of plan on most of our existing range also.

Understood. And so what about Zandu OTC? And also wanted to understand in the Zandu Healthcare, Zandu Medico, what is the key difference and what are the initiatives we have taken for this healthcare and medical piece?

Gulraj drives his business. Gulraj, please take this.

Sure, sir. So essentially for the OTC business, we have been focusing on our brand, and we launched new positioning campaigns for Pancharista and for our lithium portfolios, and we've seen strong double-digit growth in quarter one. We've also launched some new products. Which are focused on using our sales team strength and sales in distribution. So we are very hopeful that at the rest of the year also we'll be able to continue in double-digit course for the OTC business. We are also planning plans for the winter season for some of our relevant brands there. We are also looking at consolidating our rural business there in terms of our sub-stuffish towns. We had done an expansion last year, so we want to now harvest and see that they give a better throughput month-on-month and quarter-on-quarter. On the medical business, we've had some new launches which have been fairly innovative, which are seeing a good response. We are also focusing on the top Category A doctors to enhance our throughput with them. And we are also looking at getting into smaller towns in a gradual manner, which currently are being under service for the medical business.

Understood. Understood. Got it, sir. That's all from my side. Thank you.

Thank you. The next question comes from the line of Kunal Ora from BNP Paribas. Please go ahead.

Yeah, thanks. First is, there is about 500 crore investment in Exxon and in CUT. How is it being funded, and should we assume lower interest income and higher interest expense going forward, or that's largely already factored in the current run rate?

Yeah, Kunal, so it is funded internally, so whatever surplus we had, we have required that only for these acquisitions, and obviously, in this quarter, some of that has been factored. And some bit of payments would be made going ahead. So they would be slightly lower other income, obviously, compared to last year.

Okay. Slightly lower other income compared to last year. Yeah. Yeah. Yeah.

Okay.

The second is, if I look at core business, excluding the strategic investment, the growth seems to be about 3%. This is despite the GST rate cut and the strength which we are seeing in mass consumption everywhere. So, how are you seeing the growth for the portfolio, excluding the recently acquired subsidiary?

Qunal, excluding the investments, the growth rate is...

Hello, Kunal. Yeah. So excluding the domestic, if you look at our domestic business, that has grown by almost 6%. So it is only because of international it has come down and because of its own challenges in Middle East. So we have seen good growth as Mohanji said in his opening remarks in hair care business, 11%, 3% in skin care. So overall around 6% growth is there in the core business.

And how do you see it for the remainder of this year?

So we expect some better numbers only going ahead on the core business also.

Okay. Okay. Thank you.

Thank you. Ladies and gentlemen, that was the last question. I would now like to hand the conference over to the management for closing comments. Thank you, and over to you.

Thank you. Thank you all the participants for joining us today, and thank you, IFL. Thank you, Percy, for arranging this. Have a nice day. Thank you.

Thank you. On behalf of IISL and Imami, that concludes this conference. Thank you for joining us, and you may now disconnect your lines.